Stocky turns companies like CELLSOURCE CO LTD into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. 4880.T trades at a stretched 67.7× forward earnings with modest profitability momentum (Value Compounder 41/100) and tepid growth (Growth Compounder 30/100). Leadership alignment is middling (52/100), and the company carries adequate but not substantial financial buffers against downturns. Upside requires sustained margin expansion or accelerating growth to justify valuation.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for CELLSOURCE CO LTD:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 41/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates CELLSOURCE CO LTD (4880.T) at 41/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. 4880.T trades at a stretched 67.7× forward earnings with modest profitability momentum (Value Compounder 41/100) and tepid growth (Growth Compounder 30/100). Leadership alignment is middling (52/100), and the company carries adequ
4880.T's current Stocky Verdict is 41/100, placing it in the "Cautious" band. This composite combines a 41/100 Compounder score, 52/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for CELLSOURCE CO LTD yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
CELLSOURCE CO LTD scores 52/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
CELLSOURCE CO LTD's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to CELLSOURCE CO LTD.
Sign up free and unlock the full analysis on 4880.T — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 4880.T in the app.
